August 31, 2022
FDA: Class I recall of Intera 3000 Hepatic Artery Infusion Pump
Editor's Note
The Food and Drug Administration on August 29 identified the recall by Intera Oncology of its Intera 3000 Hepatic Artery Infusion Pump as Class I, the most serious.
The company is recalling the pumps after receiving reports from clinicians that the pumps were delivering medication faster than expected.
There have been reports of three incidents, with no injuries or deaths related to this issue.
Distribution dates were August 12, 2021 to May 17, 2022.
Free Daily News
- How Tampa General Hospital prepared for Hurricane Helene
- Study: Nurse manager competency indirectly impacts staff retention
- Study: Improved OR design reduces surgery time, enhances efficiency
- Hospital, health system mergers reach new heights
- Algorithm enhances decision-making on intermediate-stage liver cancer surgery, treatment
- Hispanic Heritage Month reports highlight awareness, action on organ transplant disparities
- Medicare policy on prior authorization falls short on shifting outpatient surgery trends
- DEA registration validation changes challenge healthcare accreditation
- CMS proposes $2 Drug List Model to reduce out-of-pocket costs for Medicare recipients
- Algorithm enables continuous forecasting of intraoperative blood pressure
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement